Kunwei Peng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Development and validation of HSP90AA1 as a risk gene in a HIF-1α pathway-related prognostic signature for hepatocellular carcinoma.
Journal: Biochemical and biophysical research communications
Published: March 09, 2026
A prognostic signature based on insulin-signaling-pathway genes for hepatocellular carcinoma.
Journal: Discover oncology
Published: July 12, 2025
The therapeutic promise of probiotic Bacteroides fragilis (BF839) in cancer immunotherapy.
Journal: Frontiers in microbiology
Published: November 06, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 07, 2024
MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma.
Journal: Cancer cell international
Published: November 26, 2022
Correction to: The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta‑analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: March 20, 2021
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: November 12, 2020
Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma.
Journal: Frontiers in oncology
Published: August 05, 2020
Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies.
Journal: Frontiers in oncology
Published: July 27, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026